Ginkgo Bioworks
DNA
$0.86
Share price
10.60%
Change (1 day)
-27.72%
Change (1 year)
Categories
Operating Margin for Ginkgo Bioworks (DNA)
Operating Margin as of April 2024 (TTM): -394.97%
According to Ginkgo Bioworks 's latest financial reports and stock price the company's current Operating Margin is -394.97%. At the end of 2022 the company had an Operating Margin of -444.08%.
Operating Margin history for Ginkgo Bioworks from 2021 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -444.08% | -24.18% |
| 2021 | -585.69% | 259.66% |
| 2020 | -162.85% | -26.37% |
| 2019 | -221.16% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.